eptember 10-11, 1992, p. 116-124. p> Belleguic C., Quinquenel ML, Lrena H., et al. Pulmonary metastases with a prolonged development. Two cases of thyroid cancers. // Rev Mal Respir; 1996 13 (2) :183-6
Benua R.S., Cicale N.R., Sonenberg., et al. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyriod cancer. // Am J Roentgenol Radiat Therapy Nucl Med; 1962 87:171-82
Borner A.R., Muller-Gartner H.W. Radioiodine therapy and radioiodine after-care in differentiated thyriod gland carcinomas. // ReviewZentralbl Chir; 1997 122 (4) :274-85
Burmeister L.A., du Cret R.P., Mariash C.N. Local reaction to radioiodine in the treatment of thyriod cancer. // Am J Med; 1991 90 (2) :217-22
Cailleux AF, Baudin E., Travagli JP, et al. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? // J Clin Endocrinol Metab; 2000 85 (1) :175-8
Carlisle M. Cortes A., McDougall I.R. Uptake of I-131 in the biliary tract: potential cause of false-positive result of scintiscan.// Clin Nucl Med; 1998 23 (8) :524-7
Cavalieri R.R. Nuclear imaging in the management of the thyriod carcinoma. // Thyriod; 1996 6 (5) :485-92
Ceccarelli C., Bencivelli W., Morciano D., et al. 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study. // J Clin Endocrinol Metab; 2001 86 (8) :3512-5
Chebotareva ED, Dzhuzha DA, Shishkina VV, et al. Treatment and monitoring of patients with differentiated cancer of thyroid gland. // Klin Khir; 2000 (11) :39-41
Cholewinski SP, Yoo KS, Klieger PS, O'Mara RE Absence of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I. // J Nucl Med; 2000 41 (7) :1198-202
Chopra S., Wastie M.L., Chan S., et al. Assessment of completeness of thyroid ablation by astimation of neck uptake of 131-I on whole-body scans: Comparison of quantification and visual assessment of thyroid bed uptake. // Nucl Med Commun; 1996 17: 687-91
Clark T., Becker S.V., Becker D.V. Radioiodine and clinical medicine: an historical perspectave. // International symposium on radioiodine. USA Rochester 1996. Program and Abstracts p.33
Connon CS, Thomas JH, Robinson RG, et al. Radioiodine therapy for differentiated thyriod carcinoma. // Am J Surg; 1988 156 (6) :519-21
David A., Blotta A., Bondanelli M., et al. Serum thyroglobulin concentrations and (131) I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone. // J Nucl Med; 2001 42 (10) :1470-5
de Keizer B., Koppeschaar HP, Zelissen PM, et al. Efficacy of high therapeutic doses of iodine-131 in patients with differentiated thyroid cancer and detectable serum thyroglobulin. // Eur J Nucl Med; 2001 28 (2) :198-202
De Klerk JMH, De Keizer B...
